Replisaurus has ceased ECPR operations.

 There is an extensive patent portfolio available for sale and some equipment. 

 If you are interested in acquiring any of the ECPR assets, please contact Dan Carl dacarl99@gmail.com or Guido Groet ggroet@set-sas.fr for more information.